Synopsis
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
| Molecular Weight | 205.23 g/mol |
|---|---|
| Molecular Formula | C8H17N2O4- |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 205.11883203 g/mol |
| Monoisotopic Mass | 205.11883203 g/mol |
| Topological Polar Surface Area | 130 A^2 |
| Heavy Atom Count | 14 |
| Formal Charge | -1 |
| Complexity | 131 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Related Excipient Companies
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Lysine Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lysine Acetate, including repackagers and relabelers. The FDA regulates Lysine Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lysine Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lysine Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lysine Acetate supplier is an individual or a company that provides Lysine Acetate active pharmaceutical ingredient (API) or Lysine Acetate finished formulations upon request. The Lysine Acetate suppliers may include Lysine Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Lysine Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lysine Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Lysine Acetate active pharmaceutical ingredient (API) in detail. Different forms of Lysine Acetate DMFs exist exist since differing nations have different regulations, such as Lysine Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lysine Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Lysine Acetate USDMF includes data on Lysine Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lysine Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lysine Acetate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Lysine Acetate Drug Master File in Japan (Lysine Acetate JDMF) empowers Lysine Acetate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Lysine Acetate JDMF during the approval evaluation for pharmaceutical products. At the time of Lysine Acetate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Lysine Acetate suppliers with JDMF on PharmaCompass.
A Lysine Acetate CEP of the European Pharmacopoeia monograph is often referred to as a Lysine Acetate Certificate of Suitability (COS). The purpose of a Lysine Acetate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Lysine Acetate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Lysine Acetate to their clients by showing that a Lysine Acetate CEP has been issued for it. The manufacturer submits a Lysine Acetate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Lysine Acetate CEP holder for the record. Additionally, the data presented in the Lysine Acetate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Lysine Acetate DMF.
A Lysine Acetate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Lysine Acetate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Lysine Acetate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lysine Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Lysine Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Lysine Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Lysine Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lysine Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Lysine Acetate suppliers with NDC on PharmaCompass.
Lysine Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lysine Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lysine Acetate GMP manufacturer or Lysine Acetate GMP API supplier for your needs.
A Lysine Acetate CoA (Certificate of Analysis) is a formal document that attests to Lysine Acetate's compliance with Lysine Acetate specifications and serves as a tool for batch-level quality control.
Lysine Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Lysine Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lysine Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Lysine Acetate EP), Lysine Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lysine Acetate USP).
LOOKING FOR A SUPPLIER?
